New times – new goals

By 2026, following the completion of reconstruction and a full production ramp-up, InfaPrim plans to produce up to 3 million liters of enteral nutrition per year (in liquid equivalent of dry formulas). This ambitious goal is part of a new project to modernize and expand the company’s medical nutrition production.

As part of this project, InfaPrim is building:

• A new production facility
• A warehouse for finished goods
• A laboratory and administrative complex
• Construction of the new buildings is already underway.

Once operational, the expanded site will create 50 new high-tech jobs and significantly increase overall employee productivity.

Supporting the Russian market with domestic clinical nutrition

Nutrien products are already well-known among Russian patients requiring clinical nutrition. Today, InfaPrim’s enteral nutrition accounts for approximately one-quarter of hospital market sales in Russia.

However, the majority of the market is still occupied by European manufacturers. This expansion project aims to increase the share of high-quality domestic products, helping to improve self-sufficiency in the Russian medical nutrition sector.